Marc Boucher: September 2009 Archives

Five early-career scientists were awarded The Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Awards in Alzheimer's Disease (AD). The $75,000 awards provide a broad array of funding in the biological, genetic, and environmental causes of AD. By studying the early changes suggesting Alzheimer's disease from different but complementary angles, the awards seek to accelerate development of diagnostic, preventative interventions, and treatments.

First H1N1 Vaccines Will be Nasal Spray

user-pic

The first U.S. roll-out of vaccines against the new swine flu virus will be 3.4 million doses of MedImmune's nose spray, the Centers for Disease Control and Prevention said on Friday.

In addition to breaking news and new research data from clinical trials, investigations and registries, TCT (Transcatheter Cardiovascular Therapeutics) 2009, the largest global medical and scientific symposium dedicated to interventional cardiovascular medicine, will feature an important discussion led by national experts on Electronic Health Records (EHR).

THE PRESIDENT: Madam Speaker, Vice President Biden, members of Congress, and the American people: When I spoke here last winter, this nation was facing the worst economic crisis since the Great Depression. We were losing an average of 700,000 jobs per month. Credit was frozen. And our financial system was on the verge of collapse.

The current issue of Nature Medicine has an informative article by Charlotte Schubert, senior editor for News and Views on the power of adjuvants in vaccines including H1N1.

Dr. Tachi Yamada, president of the Gates Foundation's global health program believes that poorer nations without the funds or ability to produce a vaccine for H1N1 should get equal access to the limited supplies even if the richer countries paid for and developed the vaccine.

With the flu season fast approaching the President today provided an overview of what's being done. The Secretary of Health and Human Services is leading the way on public health preparedness and response efforts, the Principal Federal Official for domestic incidents, the Secretary of Homeland Security, is coordinating the supporting activities of Federal departments and agencies and facilitating response actions with State, local and territorial governments and tribal and private sector partners, while other Cabinet officials are leading complementary initiatives in their area of responsibility.

Researchers Dr. Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and Dr. Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer therapies.